On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugs
Authors
Keywords
IMiDs, CRBN, Cancer therapy, Microscale thermophoresis, MST
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 534, Issue -, Pages 67-72
Publisher
Elsevier BV
Online
2020-12-11
DOI
10.1016/j.bbrc.2020.11.117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design and synthesis of new lenalidomide analogs via Suzuki cross‐coupling reaction
- (2020) Donghuai Xiao et al. ARCHIV DER PHARMAZIE
- Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs
- (2020) Shaunna L. Beedie et al. FASEB JOURNAL
- Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay
- (2020) Samuel Maiwald et al. ACS Medicinal Chemistry Letters
- Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs
- (2019) Miriam Girardini et al. BIOORGANIC & MEDICINAL CHEMISTRY
- De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives
- (2019) Christopher Heim et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Thalidomide-Resembling Dicarboximides Target ABC50 Protein and Show Antileukemic and Immunomodulatory Activities
- (2019) Marcin Cieślak et al. Biomolecules
- Bifunctional chemical probes inducing protein–protein interactions
- (2019) Chiara Maniaci et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure-Degradation Relationships
- (2018) George M. Burslem et al. ChemMedChem
- Homo-PROTACs for the Chemical Knockdown of Cereblon
- (2018) Christian Steinebach et al. ACS Chemical Biology
- Synthesis, Structural Characterization, and Antiangiogenic Activity of Polyfluorinated Benzamides
- (2018) Christian Steinebach et al. ChemMedChem
- Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others
- (2017) Etsuko Tokunaga et al. PLoS One
- Synthesis and Antiangiogenic Properties of Tetrafluorophthalimido and Tetrafluorobenzamido Barbituric Acids
- (2016) Agnieszka Ambrożak et al. ChemMedChem
- A FRET-Based Assay for the Identification and Characterization of Cereblon Ligands
- (2016) Iuliia Boichenko et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
- (2016) Georg Petzold et al. NATURE
- Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
- (2015) Ashton C. Lai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues
- (2015) S. L. Beedie et al. MOLECULAR CANCER THERAPEUTICS
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Structural Dynamics of the Cereblon Ligand Binding Domain
- (2015) Marcus D. Hartmann et al. PLoS One
- In vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs
- (2014) Bishoy Y.A. El-Aarag et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Thalidomide mimics uridine binding to an aromatic cage in cereblon
- (2014) Marcus D. Hartmann et al. JOURNAL OF STRUCTURAL BIOLOGY
- Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide
- (2014) Eric S. Fischer et al. NATURE
- Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs
- (2014) Philip P Chamberlain et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- Recent advances of IMiDs in cancer therapy
- (2010) Shirong Li et al. CURRENT OPINION IN ONCOLOGY
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions
- (2008) Ling Lu et al. MICROVASCULAR RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started